{
    "2018-03-22": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Is Geron Corporation Stock Still a Strong Buy?",
                "features": {
                    "keywords": [
                        "Geron",
                        "Strong Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "4 Reasons Why Glaxo (GSK) Stock Can be a Great Pick in '18",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Great Pick",
                        "2018"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "MARKETS: Forget 3 rate hikes in 2018—Bill Gross says 2 max",
                "features": {
                    "keywords": [
                        "rate hikes",
                        "Bill Gross"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "VIG, GASX: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "ETF",
                        "Outflows"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets",
                "features": {
                    "keywords": [
                        "Obese Countries",
                        "Anti-Obesity Drug"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Biotech Winners And Losers From Congress' Latest Funding Bill",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Winners",
                        "Losers",
                        "Congress",
                        "Funding"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Gilead’s HCV Drugs Performed in 2017",
                "features": {
                    "keywords": [
                        "Gilead",
                        "HCV Drugs",
                        "Performed"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Facebook’s Zuckerberg had 15 minutes to respond to privacy crisis — he took four days",
                "features": {
                    "keywords": [
                        "Facebook",
                        "Zuckerberg",
                        "Privacy Crisis"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "See what the IHS Markit Score report has to say about Johnson & Johnson.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Gilead Sciences’ TAF-Containing HIV Drugs Performed",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "TAF-Containing",
                        "HIV Drugs"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Bloomberg Big Decisions: Johnson & Johnson CEO Alex Gorsky",
                "features": {
                    "keywords": [
                        "Bloomberg",
                        "Big Decisions",
                        "Johnson & Johnson",
                        "Alex Gorsky"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}